Latest Advances

  • Condition: NRAS-Mutated Metastatic Melanoma
  • Journal: Journal of cancer research and therapeutics
  • Treatment Used: MEK inhibitor, Cobimetinib, First-Line Treatment
  • Number of Patients: 0
  • Published —
This case report described an 84-year-old patient diagnosed with NRAS-mutated metastatic melanoma treated with the MEK inhibitor, cobimentinib, as first-line treatment.
  • Condition: Severe Cytomegalovirus (CMV) Gastritis after Pembrolizumab in Patient with Melanoma
  • Journal: Current oncology (Toronto, Ont.)
  • Treatment Used: Antiviral Therapy with Ganciclovir
  • Number of Patients: 1
  • Published —
This case report describes a 43-year-old woman with melanoma who developed severe cytomegalovirus (CMV) gastritis after receiving pembrolizumab treated with antiviral therapy, ganciclovir.
  • Condition: Cancer
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Immune Checkpoint Inhibitors (ICIs)
  • Number of Patients: 0
  • Published —
This article discusses treatment duration in cancer patient responders to immune checkpoint inhibitors (ICIs).
  • Condition: Adult Patient with Primary Malignant Melanoma of Bowel Following Bowel Intussusception
  • Journal: Annali italiani di chirurgia
  • Treatment Used: Surgery and Immunotherapy
  • Number of Patients: 1
  • Published —
This case report describes a 77-year-old female diagnosed with primary malignant melanoma of the bowel diagnosed following a bowel intussusception treated with surgery and immunotherapy.
  • Condition: Patients with Checkpoint Inhibitor-Associated Acute Tubular Interstitial Nephritis (ATIN)
  • Journal: Oncoimmunology
  • Treatment Used: Infliximab
  • Number of Patients: 0
  • Published —
This study evaluated for an infliximab-containing regimen for treatment of relapsed checkpoint inhibitor (CPI)-acute tubular interstitial nephritis (ATIN) in patients failing to achieve complete response after primary therapy.
  • Condition: Multiple Endocrinopathies, Hypercalcemia and Pancreatitis Following Combined Immune Checkpoint Inhibitor (ICI) Use
  • Journal: BMC endocrine disorders
  • Treatment Used: Zoledronic Acid and Oral Prednisolone
  • Number of Patients: 1
  • Published —
This case report describes a 46-year old Caucasian female with malignant melanoma and lung metastases who developed multiple endocrinopathies, hypercalcemia, and pancreatitis following combined immune checkpoint inhibitor use treated with zoledronic acid and oral prednisolone.
  • Condition: Acute Graft-Versus-Host Disease (GVHD) in Patients with Acute Myeloid Leukemia/Myelodysplastic Syndromes
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Post-Transplantation Cyclophosphamide
  • Number of Patients: 21
  • Published —
This study analyzed graft-versus-host disease (GVHD) prophylaxis in patients with acute myeloid leukemia/myelodysplastic syndromes who had received immune checkpoint inhibitors (ICIs) therapy after allogeneic hematopoietic stem cell transplantation (alloHCT).
  • Condition: Melanoma
  • Journal: Medical oncology (Northwood, London, England)
  • Treatment Used: Kiwifruit Extract (KE)
  • Number of Patients: NULL
  • Published —
This study investigated whether kiwifruit extract (KE) had any effect on melanoma ( type of skin cancer) cancer cells.
  • Condition: Steroid-Refractory/Resistant Pneumonitis Related to Immune Checkpoint Blockade
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Additional Immune Modulators
  • Number of Patients: 26
  • Published —
This study evaluated the use of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade.
  • Condition: Metastatic Melanoma Brain Metastases (MBM)
  • Journal: Radiation oncology (London, England)
  • Treatment Used: Whole Brain Radiotherapy (WBRT)
  • Number of Patients: 63
  • Published —
This study reported outcomes for patients with melanoma with brain metastases (MBM) treated with whole brain radiotherapy.
  • Condition: Stage III Melanoma
  • Journal: Nature medicine
  • Treatment Used: OpACIN-Neo and OpACIN Neoadjuvant Immunotherapy
  • Number of Patients: 86
  • Published —
This study tested the safety and efficacy of using OpACIN-neo and OpACIN neoadjuvant immunotherapy to treat patients with stage III melanoma.
  • Condition: Lower Genital Tract Melanomas
  • Journal: Anticancer research
  • Treatment Used: Surgery
  • Number of Patients: 20
  • Published —
The study researched treatment of lower genital tract melanoma.
Showing 1-12 of 532